Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness
- PMID: 23307531
- PMCID: PMC3596470
- DOI: 10.1158/1055-9965.EPI-12-1183-T
Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness
Abstract
Background: Approximately half of epithelial ovarian cancers are fatal within 3 years; however, roughly 35% of women survive for at least 10 years. In the Nurses' Health Study, New England Case-Control Study, Australian Ovarian Cancer Study, and NIH-AARP Diet and Health Study, we investigated potential differences in the associations with ovarian cancer risk factors by tumor aggressiveness, defined on the basis of time from diagnosis until death.
Methods: We calculated relative risks (RR) and 95% confidence intervals (CI) for associations of known or suspected ovarian cancer risk factors with rapidly fatal (death within 3 years of diagnosis) and less aggressive tumors (all others) using Cox proportional hazards competing risks analysis (NHS and AARP) or polytomous logistic regression (NECC, AOCS). Results were combined using random effects meta-analysis.
Results: Increasing age was associated with greater risk of rapidly fatal versus less aggressive disease (RR, 5-year increase: 1.39; 95% CI, 1.29-1.49 vs. RR, 1.09; 95% CI, 1.03-1.16, respectively; Pdiff < 0.0001). Oral contraceptive use was associated with a greater decreased risk of rapidly fatal (RR, 5-year increase: 0.69; 95% CI, 0.58-0.82) versus less aggressive disease (RR, 0.81; 95% CI, 0.74-0.89; Pdiff, 0.002). Conversely, increasing parity was associated only with less aggressive disease (RR per child, 0.87; 95% CI, 0.81-0.93).
Conclusion: In this analysis of 4,342 cases, there were clear differences in risk factors for rapidly fatal versus less aggressive ovarian tumors.
Impact: Differences in risk factor associations by tumor aggressiveness suggests the developmental pathways through which the tumors develop and may be important for developing primary preventive strategies for the most aggressive cancers.
Conflict of interest statement
The authors have no conflicts of interest.
Similar articles
-
Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.Int J Cancer. 2013 Aug 1;133(3):730-9. doi: 10.1002/ijc.28064. Epub 2013 Mar 13. Int J Cancer. 2013. PMID: 23364849 Free PMC article.
-
The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.Gynecol Oncol. 2016 Dec;143(3):628-635. doi: 10.1016/j.ygyno.2016.09.024. Epub 2016 Oct 5. Gynecol Oncol. 2016. PMID: 27720231 Free PMC article.
-
A prospective study of phobic anxiety, risk of ovarian cancer, and survival among patients.Cancer Causes Control. 2016 May;27(5):661-8. doi: 10.1007/s10552-016-0739-0. Epub 2016 Mar 29. Cancer Causes Control. 2016. PMID: 27023470 Free PMC article.
-
Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.Acta Obstet Gynecol Scand. 2004 Sep;83(9):783-95. doi: 10.1111/j.0001-6349.2004.00550.x. Acta Obstet Gynecol Scand. 2004. PMID: 15315588 Review.
-
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.Am J Epidemiol. 2017 Jan 1;185(1):8-20. doi: 10.1093/aje/kww161. Epub 2016 Dec 9. Am J Epidemiol. 2017. PMID: 27941069 Free PMC article. Review.
Cited by
-
Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women.Endocr Connect. 2018 Sep 1;7(9):1006-1012. doi: 10.1530/EC-18-0158. Endocr Connect. 2018. PMID: 30012649 Free PMC article.
-
Association of Ovarian Tumor β2-Adrenergic Receptor Status with Ovarian Cancer Risk Factors and Survival.Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1587-1594. doi: 10.1158/1055-9965.EPI-16-0534. Epub 2016 Sep 1. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27587791 Free PMC article.
-
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.J Clin Oncol. 2016 Aug 20;34(24):2888-98. doi: 10.1200/JCO.2016.66.8178. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325851 Free PMC article.
-
Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study.Am J Public Health. 2016 Sep;106(9):1631-7. doi: 10.2105/AJPH.2016.303349. Epub 2016 Jul 26. Am J Public Health. 2016. PMID: 27459451 Free PMC article. Review.
-
A Multi-State Survival Model for Time to Breast Cancer Mortality among a Cohort of Initially Disease-Free Women.Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1582-1592. doi: 10.1158/1055-9965.EPI-21-1471. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35654356 Free PMC article.
References
-
- Cancer Facts & Figures 2011. Atlanta: American Cancer Society; 2011.
-
- Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975–2008. Based on November 2010 SEER data submission, Posted to the SEER web site. 2011 Available from: http://seer.cancer.gov/csr/1975_2008/
-
- Steffensen K, Waldstrom M, Grove A, Lund B, Pallisgard N, Jakobsen A. Improved classification of epithelial ovarian cancer: Results of 3 Danish cohorts. Int J Gynecol Pathol. 2011;21:1592–600. - PubMed
-
- Colditz GA, Hankinson SE. The Nurses’ Health Study: lifestyle and health among women. Nat Rev Cancer. 2005;5:388–96. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases